Glenmark Pharma gets USFDA nod for acid reflux medication

Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of AstraZeneca’s Nexium, used to treat acid reflux. The company has been granted final approval by the United States Food & Drug Administration (USFDA) for esomeprazole magnesium delayed-release capsules USP in the strengths of 20 mg and 40 mg.

The approved product is a generic version of AstraZeneca Pharmaceuticals’ Nexium delayed-release capsules.